AMLX · Amylyx Pharmaceuticals, Inc.
$18.50
+1.05 (+6.02%)
At close · Jul 21
Market Cap
$2.06B
Shares
111.19M
Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Short Squeeze Score
85/100
Short interest 12.9% of shares — P93
Days to cover 7.1 — P90
Price vs VWAP +14.8% — P92
Short-volume trend +19.0% — P94
Short interest change +9.6% — P66
Worst FTD 0.01% of shares — P44
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
| 2026-06-30 | 14,385,180 | 13,121,697 | +1,263,483 | 7.06 |
| 2026-06-15 | 13,121,697 | 14,957,523 | -1,835,826 | 8.12 |
| 2026-05-29 | 14,957,523 | 14,514,401 | +443,122 | 16.33 |
| 2026-05-15 | 14,514,401 | 14,800,969 | -286,568 | 12.16 |
| 2026-04-30 | 14,800,969 | 14,831,510 | -30,541 | 14.26 |
| 2026-04-15 | 14,831,510 | 14,231,261 | +600,249 | 12.23 |
| 2026-03-31 | 14,231,261 | 13,864,210 | +367,051 | 14.14 |
| 2026-03-13 | 13,864,210 | 14,497,298 | -633,088 | 12.49 |
| 2026-02-27 | 14,497,298 | 14,310,589 | +186,709 | 19.07 |
| 2026-02-13 | 14,310,589 | 13,752,736 | +557,853 | 17.43 |
| 2026-01-30 | 13,752,736 | 13,437,426 | +315,310 | 6.59 |
| 2026-01-15 | 13,437,426 | 13,642,380 | -204,954 | 7.70 |
| 2025-12-31 | 13,642,380 | 12,068,995 | +1,573,385 | 7.51 |
| 2025-12-15 | 12,068,995 | 11,623,612 | +445,383 | 10.90 |
| 2025-11-28 | 11,623,612 | 11,911,669 | -288,057 | 8.31 |
| 2025-11-14 | 11,911,669 | 10,449,446 | +1,462,223 | 7.48 |
| 2025-10-31 | 10,449,446 | 9,616,175 | +833,271 | 6.85 |
| 2025-10-15 | 9,616,175 | 10,066,534 | -450,359 | 5.01 |
| 2025-09-30 | 10,066,534 | 8,774,952 | +1,291,582 | 5.09 |
| 2025-09-15 | 8,774,952 | 8,410,918 | +364,034 | 3.88 |
| 2025-08-29 | 8,410,918 | 7,433,417 | +977,501 | 5.44 |
| 2025-08-15 | 7,433,417 | 7,192,631 | +240,786 | 8.35 |
| 2025-07-31 | 7,192,631 | 7,466,420 | -273,789 | 5.92 |
Showing 1–23 of 23 settlements
Key facts
CIK
1658551
CUSIP
03237H101
13F (30d)
10 filings
10 filers
Visit website
Investor relations